Weeks, not months
The pricing page gives each injectable rung a period: four weeks for most, five weeks for one of them. That is not a rounding of a month. A four-week cycle repeats thirteen times a year against a month's twelve, so a figure read as monthly understates the annual cost by roughly one cycle.
This page records those rows without a per-month suffix for exactly that reason. Omitting the suffix asserts nothing while the qualifier still carries the term; printing it would assert a fact the seller has not stated. The oral tablets sold per thirty days are recorded as monthly, and the ninety-day sizes are not.
Two routes and a real ladder
Both molecules are offered as injectables across six levels and as orally dissolving tablets at three strengths, in thirty-day and ninety-day supplies. The weekly dose is printed beside every injectable rung, so a reader can match a price to where they expect to be in the titration schedule rather than to where they start.
The price roughly doubles across the ladder on both drugs. That is normal for a dose-tiered seller and it is disclosed here more completely than most, but the headline remains the bottom rung.
What the figure covers
The pricing page states the figure includes the visit and the pass-through cost of medication shipped by the preparing compounding pharmacy, and that there are no contracts or long-term commitments. That makes the figure a bill rather than a component, and it is why the membership position here is recorded as included rather than as unaddressed.
It is also worth noting what pass-through means. The site is describing itself as not marking up the drug, which is a claim about its own margin rather than about the total, and nothing on the page lets a reader check it.
The page is not finished
Several rungs on the pricing table still carry the placeholder text that ships with an unedited template. That is cosmetic rather than substantive, but it is a signal about how recently the commercial detail was reviewed, and the verification date on every figure here should be read with that in mind.
The compounding pharmacy is referred to only as the preparing pharmacy and never named. No list of states served appears anywhere we read, and no individual prescribing clinician or medical director is identified.
Rixa Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $195per 4 weeks, as the pricing page states — thirteen four-week cycles fit in a year, so this is not a calendar-month rate | September 2026source |
| Semaglutide (compounded) | $265per 5 weeks, as the pricing page states — the supply period changes between rungs of this ladder, and this rung covers five weeks rather than four | September 2026source |
| Semaglutide (compounded-oral) | $140/moper 30 days, as the pricing page states | September 2026source |
| Semaglutide (compounded-oral) | $575per 90 days, as the pricing page states — a quarter, not a month | September 2026source |
| Tirzepatide (compounded) | $280per 4 weeks, as the pricing page states — not a calendar month | September 2026source |
| Tirzepatide (compounded) | $525per 4 weeks at the top of the published six-level ladder — not a calendar month | September 2026source |
| Tirzepatide (compounded-oral) | $225/moper 30 days, as the pricing page states | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 283 providers reviewed here are paid partners today; the other 279 are not. See how this works.
See Rixa Health's current price →Good fit if
- Readers who want the supply period stated in the same breath as the price.
- Patients comparing an oral tablet against an injection, both of which are priced here at several strengths.
- Anyone who wants a quarter of treatment priced as a quarter rather than as three implied months.
- Readers who want the weekly dose printed beside every rung of the ladder.
Look elsewhere if
- Anyone who will read a four-week price as a monthly one, which is the mistake this pricing table invites and rewards.
- Readers who need the compounding pharmacy named.
- Patients who must confirm their state is served before starting.
- Anyone attracted by the entry rung; the price roughly doubles by the top of the ladder on both drugs.
How this review was verified
- Read the pricing page and the medical weight loss page at their source URLs and logged each figure with the date it was read.
- Took the supply period from the page itself for every row, and recorded the four-week and five-week and ninety-day figures without a per-month suffix.
- Recorded the thirty-day oral tablet figures as monthly, since a thirty-day supply is a month as the page states it.
- Took the membership position from the pricing page statement about what the figure covers, rather than inferring it from the absence of a fee.
- Pulled all 3,677 rows of the FDA warning-letter table and filtered them locally with a known-positive and a nonsense-string control in the same run; no letter found.